
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
ICCE (2025)
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 3
May-June 2025
Indexing Partners



















Non-Invasive Vaccine Delivery System- A Review
Author(s) | Ms. JYOTHI KRISHNA V, Ms. DIVYA DHARSHINI J, Mr. RAHUL RAMESH, Ms. ANUJHA SELLAMUTHU |
---|---|
Country | India |
Abstract | Edible vaccines refer to a new method of administering vaccines where genetically engineered plants are employed to vaccinate against diseases by inducing the desired immune response without having to use needles and syringes to inject the vaccine. In this case, vaccines are introduced into the foods that are consumed by human beings. As plants that contain the antigen are consumed, the antigen induces the desired immune response. The first process involves selecting an immunoglobulin gene from a bacterium. To achieve this, the immunoglobulin gene is then incorporated into a cloning vector. The vector is then introduced into the plant using Agrobacterium tumefaciens. The plant is then allowed to grow in plant tissue culture (PTC) to ensure that the antigen is stable. The plant is then allowed to mature. The mature plant is then allowed to produce the required antigen. The plant is then harvested and the antigen extracted. The plant is then allowed to produce the antigen in a bioreactor. This is followed by assessing the quantity of antigen that is being produced. The process of assessing the quantity of protein is carried out in a laboratory. The vaccines are then processed in the laboratory. The goal of this stage is to produce a biopharmaceutical that will be required for vaccination. The vaccine is then tested to ensure that it will be efficient in inducing the desired immune response. In this case, the antigenic protein is assessed to ensure that it is the protein that will stimulate the production of antibodies. During the process of producing an edible vaccine, the gene and the encoded protein are determined by using a suitable method. In this case, the DNA is determined by carrying out Polymerase chain reaction. The process of separating the gene from the rest of the human gene involves carrying out electrophoresis This approach improves vaccine accessibility, particularly in resource-limited regions, eliminating cold chain dependencies and reducing risks associated with injectable vaccines, thereby revolutionizing global immunization strategies. |
Keywords | Edible vaccines, Agrobacterium tumefaciens, Immunoglobulin gene, Plant Tissue Culture (PTC), Polymerase Chain Reaction (PCR). |
Field | Biology > Genetics / Molecular |
Published In | Volume 7, Issue 3, May-June 2025 |
Published On | 2025-05-11 |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
